Kisspeptin in the Evaluation of Delayed Puberty

Status Completed

Clinical Trial Summary

The goal of this study is to test whether the hormone kisspeptin has the potential to prospectively diagnose adolescents with self-resolving or permanent delayed puberty. Some children with delayed puberty will eventually enter puberty on their own. However, some children with delayed puberty have a permanent condition and require medical treatment to undergo puberty. Right now, there is no reliable diagnostic tool to tell whether a child's delayed puberty will be self-resolving or permanent. The hormone kisspeptin has the potential to prospectively diagnose adolescents with self-resolving or permanent delayed puberty.

Clinical Trial Description

The investigators are seeking boys (ages 13.5-17 years) and girls (ages 12-17) years with a diagnosis of delayed puberty. Study participation involves 2 outpatient visits and two hospital admissions (one 11-hour, overnight admission and one 6-hour day admission) when subjects will receive two investigational drugs, the naturally occurring hormones kisspeptin and gonadotropin-releasing hormone (GnRH). Subjects will then be followed every 6 months until they reach 18 years of age to determine if their pubertal delay was self-resolved or permanent. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01438034
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	Phase 1
Start date	June 8, 2013
Completion date	September 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01438073` - Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling	Phase 1
Completed	`NCT01403532` - Sequential Therapy for Hypogonadotropic Hypogonadism	Phase 4
Recruiting	`NCT00456274` - Baselines in Reproductive Disorders	N/A
Terminated	`NCT05205837` - A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial	Phase 4
Completed	`NCT02908074` - A 6 Month Safety Extension Study of MBGS205	Phase 2
Completed	`NCT05752591` - Hypothalamic-pituitary Dysfunction in Diabetes
Terminated	`NCT03118479` - Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)	Phase 1
Completed	`NCT02730169` - Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism	Phase 2
Completed	`NCT02110368` - Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions	Phase 3
Recruiting	`NCT01601171` - Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Completed	`NCT01623570` - Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP	N/A
Terminated	`NCT00328926` - Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])	Phase 4
Completed	`NCT04456296` - A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism	Phase 4
Recruiting	`NCT00914823` - Kisspeptin Administration in the Adult	Phase 1
Terminated	`NCT01155518` - Hypogonadism in Young Men With Type 2 Diabetes	Phase 2
Completed	`NCT00697814` - Clomiphene in Males With Prolactinomas and Persistent Hypogonadism	Phase 2
Active, not recruiting	`NCT00351416` - Letrozole Treatment in Normal and GnRH Deficient Women	Phase 2/Phase 3
Recruiting	`NCT05971836` - The Molecular Basis of Inherited Reproductive Disorders
Recruiting	`NCT02705014` - Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome	N/A
Recruiting	`NCT04648969` - Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism	Phase 2